These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 31877419)

  • 1. Sleep and Overactive Bladder in Parkinson's Disease.
    Zheng Y; Cameron AP
    Urol Clin North Am; 2024 May; 51(2):197-207. PubMed ID: 38609192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nocturia in Parkinson's disease].
    Pilipovich AA; Vorob'eva OV; Makarov SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):48-54. PubMed ID: 38676677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Lower urinary tract dysfunction in animal models of Parkinson's disease (PD): Translational aspects for the treatment of PD patients with overactive bladder.
    Kitta T; Ogawa T; Kuno S; Kakizaki H; Yoshimura N
    Int Rev Neurobiol; 2024; 174():211-230. PubMed ID: 38341230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Polypharmacy on Management of Lower Urinary Tract Symptoms in Parkinson's Disease.
    Saraf U; Batla A; Sakakibara R; Panicker JN
    Drugs Aging; 2023 Oct; 40(10):909-917. PubMed ID: 37651023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of the Diaphragm in Postural Stability and Visceral Function in Parkinson's Disease.
    Yu X; Jiang HY; Zhang CX; Jin ZH; Gao L; Wang RD; Fang JP; Su Y; Xi JN; Fang BY
    Front Aging Neurosci; 2021; 13():785020. PubMed ID: 35002681
    [No Abstract]   [Full Text] [Related]  

  • 6. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic Dysfunctions in Parkinson's Disease: Prevalence, Clinical Characteristics, Potential Diagnostic Markers, and Treatment.
    Zhang Z; Chen SD
    Parkinsons Dis; 2020; 2020():8740732. PubMed ID: 33425317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic Dysfunction in Parkinson's Disease.
    Pfeiffer RF
    Neurotherapeutics; 2020 Oct; 17(4):1464-1479. PubMed ID: 32789741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder function of patients with Parkinson's disease.
    Sakakibara R; Tateno F; Nagao T; Yamamoto T; Uchiyama T; Yamanishi T; Yano M; Kishi M; Tsuyusaki Y; Aiba Y
    Int J Urol; 2014 Jul; 21(7):638-46. PubMed ID: 24571321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of bladder dysfunction in Parkinson's disease.
    Sakakibara R; Tateno F; Kishi M; Tsuyuzaki Y; Uchiyama T; Yamamoto T
    Neurobiol Dis; 2012 Jun; 46(3):565-71. PubMed ID: 22015601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study.
    Brusa L; Ponzo V; Stefani A; Ceravolo R; Palermo G; Agrò EF; Viselli F; Altavista MC; Iani C; Stocchi F; Stanzione P; Vitale C
    J Neurol Sci; 2020 Mar; 410():116625. PubMed ID: 31877419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.
    Liu Z; Uchiyama T; Sakakibara R; Yamamoto T
    Int Urol Nephrol; 2015 May; 47(5):751-7. PubMed ID: 25792006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon.
    Uchiyama T; Sakakibara R; Hattori T; Yamanishi T
    Mov Disord; 2003 May; 18(5):573-8. PubMed ID: 12722172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
    Taguchi S; Koide H; Oiwa H; Hayashi M; Ogawa K; Ito C; Nakashima K; Yuasa T; Yasumoto A; Ando H; Fujikake A; Fukuoka T; Tokui K; Izumi M; Tsunoda Y; Kawagashira Y; Okada Y; Niwa JI; Doyu M
    PLoS One; 2021; 16(7):e0255274. PubMed ID: 34320022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.